PrEPWatch Logo
An Initiative of AVAC
  • About PrEP
    • The Basics
    • About Oral PrEP
    • Evidence & Research for Oral PrEP
    • About the Dapivirine Vaginal Ring
    • Evidence & Research for the Dapivirine Vaginal Ring
    • About Cabotegravir (CAB-LA)
    • Evidence and Research for Cabotegravir (CAB-LA)
  • PrEP Planning A-Z
    • PrEP Communications Accelerator
    • OPTIONS Plan 4 PrEP Toolkit
    • Policies, Plans and Budgets
    • Supply Chain Management
    • Delivery Issues & Best Practices
    • Promoting Demand & Uptake Adherence
    • Monitoring & Evaluation
  • In Practice
    • Implementation Initiatives and Partners
    • Lessons from the Field
    • Global PrEP Tracker
    • Country Updates
    • Virtual Learning Network
    • West Africa Regional PrEP Learning Network
  • Resources
  • Next-Gen
    • The Dual Prevention Pill
    • Research Pipeline
  • Populations Spotlight
    • HIV Prevention among Pregnant and Breastfeeding People
  • About PrEP
    • The Basics
    • About Oral PrEP
    • Evidence & Research for Oral PrEP
    • About the Dapivirine Vaginal Ring
    • Evidence & Research for the Dapivirine Vaginal Ring
    • About Cabotegravir (CAB-LA)
    • Evidence and Research for Cabotegravir (CAB-LA)
  • PrEP Planning A-Z
    • PrEP Communications Accelerator
    • OPTIONS Plan 4 PrEP Toolkit
    • Policies, Plans and Budgets
    • Supply Chain Management
    • Delivery Issues & Best Practices
    • Promoting Demand & Uptake Adherence
    • Monitoring & Evaluation
  • In Practice
    • Implementation Initiatives and Partners
    • Lessons from the Field
    • Global PrEP Tracker
    • Country Updates
    • Virtual Learning Network
    • West Africa Regional PrEP Learning Network
  • Resources
  • Next-Gen
    • The Dual Prevention Pill
    • Research Pipeline
  • Populations Spotlight
    • HIV Prevention among Pregnant and Breastfeeding People
  • Home
  • In Practice
  • Virtual Learning Network
  • OPTIONS_LearningNetwork_FinalSlides
PrEP Watch is a one-stop for PrEP data, research, cost, access, implementation and advocacy efforts across the globe. Learn more about PrEP
Connect with us
Email
Facebook
Twitter
  • About PrEP
    • The Basics
    • About Oral PrEP
    • Evidence & Research for Oral PrEP
    • About the Dapivirine Vaginal Ring
    • Evidence & Research for the Dapivirine Vaginal Ring
    • About Cabotegravir (CAB-LA)
    • Evidence and Research for Cabotegravir (CAB-LA)
  • PrEP Planning A-Z
    • PrEP Communications Accelerator
    • OPTIONS Plan 4 PrEP Toolkit
    • Policies, Plans and Budgets
    • Supply Chain Management
    • Delivery Issues & Best Practices
    • Promoting Demand & Uptake Adherence
    • Monitoring & Evaluation
  • In Practice
    • Implementation Initiatives and Partners
    • Lessons from the Field
    • Global PrEP Tracker
    • Country Updates
    • Virtual Learning Network
    • West Africa Regional PrEP Learning Network
  • Resources
  • Next-Gen
    • The Dual Prevention Pill
    • Research Pipeline
  • Populations Spotlight
    • HIV Prevention among Pregnant and Breastfeeding People
PrEP Communications Accelerator
OPTIONS Accelerator
Fast tracking PrEP uptake through strategic communications and demand creation. Get started!
AVAC

PrEPWatch was created in 2006 and is maintained by AVAC, a non-profit organization based in New York that uses education, policy analysis, advocacy and a network of global collaborations to accelerate the ethical development and global delivery of new and emerging HIV prevention options as part of a comprehensive and integrated pathway to global health equity. AVAC receives support for PrEPWatch from various sources including the Bill & Melinda Gates Foundation, the Children’s Investment Fund Foundation and USAID, via OPTIONS, PROMISE and MOSAIC projects. AVAC accepts no money from pharmaceutical companies, including Gilead Sciences and ViiV Healthcare. If you have a comment or suggestion regarding the content of this site, click here to contact us. Read our privacy policy.